These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26827257)

  • 41. A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence.
    LaRowe SD; Kalivas PW; Nicholas JS; Randall PK; Mardikian PN; Malcolm RJ
    Am J Addict; 2013; 22(5):443-52. PubMed ID: 23952889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis.
    Faridi K; Joober R; Malla A
    Schizophr Res; 2012 Oct; 141(1):78-82. PubMed ID: 22910403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-occurring marijuana use is associated with medication nonadherence and nonplanning impulsivity in young adult heavy drinkers.
    Peters EN; Leeman RF; Fucito LM; Toll BA; Corbin WR; O'Malley SS
    Addict Behav; 2012 Apr; 37(4):420-6. PubMed ID: 22189052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adherence to medication is associated with non-planning impulsivity in euthymic bipolar disorder patients.
    Belzeaux R; Boyer L; Mazzola-Pomietto P; Michel P; Correard N; Aubin V; Bellivier F; Bougerol T; Olie E; Courtet P; Etain B; Gard S; Kahn JP; Passerieux C; Leboyer M; Henry C; Azorin JM;
    J Affect Disord; 2015 Sep; 184():60-6. PubMed ID: 26070047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.
    Schuster RM; Potter K; Vandrey R; Hareli M; Gilman J; Schoenfeld D; Evins AE
    J Psychopharmacol; 2020 Feb; 34(2):197-210. PubMed ID: 31535597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can cannabis use be prevented by targeting personality risk in schools? Twenty-four-month outcome of the adventure trial on cannabis use: a cluster-randomized controlled trial.
    Mahu IT; Doucet C; O'Leary-Barrett M; Conrod PJ
    Addiction; 2015 Oct; 110(10):1625-33. PubMed ID: 26011508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Goal commitment predicts cannabis use for adolescents in treatment.
    Kaminer Y; Ohannessian CM; Burke RH
    Subst Abus; 2019; 40(4):496-500. PubMed ID: 30810498
    [No Abstract]   [Full Text] [Related]  

  • 48. Are adolescents gambling with cannabis use? A longitudinal study of impulsivity measures and adolescent substance use: the TRAILS study.
    Prince van Leeuwen A; Creemers HE; Verhulst FC; Ormel J; Huizink AC
    J Stud Alcohol Drugs; 2011 Jan; 72(1):70-8. PubMed ID: 21138713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
    Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alcohol substitution during one month of cannabis abstinence among non-treatment seeking youth.
    Schuster RM; Potter K; Lamberth E; Rychik N; Hareli M; Allen S; Broos HC; Mustoe A; Gilman JM; Pachas G; Evins AE
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110205. PubMed ID: 33309538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Who responds to a multi-component treatment for cannabis use disorder? Using multivariable and machine learning models to classify treatment responders and non-responders.
    Tomko RL; Wolf BJ; McClure EA; Carpenter MJ; Magruder KM; Squeglia LM; Gray KM
    Addiction; 2023 Oct; 118(10):1965-1974. PubMed ID: 37132085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials.
    Baker NL; Gray KM; Sherman BJ; Morella K; Sahlem GL; Wagner AM; McRae-Clark AL
    Drug Alcohol Depend; 2018 Jun; 187():270-277. PubMed ID: 29698894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.
    Sherman BJ; McRae-Clark AL; Baker NL; Sonne SC; Killeen TK; Cloud K; Gray KM
    Am J Addict; 2017 Mar; 26(2):136-144. PubMed ID: 28152236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabis and alcohol use, affect and impulsivity in psychiatric out-patients' daily lives.
    Trull TJ; Wycoff AM; Lane SP; Carpenter RW; Brown WC
    Addiction; 2016 Nov; 111(11):2052-2059. PubMed ID: 27270874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol.
    Maier A; Dharan A; Oliver G; Berk M; Redston S; Back SE; Kalivas P; Ng C; Kanaan RA
    BMC Psychiatry; 2020 Aug; 20(1):397. PubMed ID: 32762663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.
    McRae-Clark AL; Baker NL; Gray KM; Killeen TK; Wagner AM; Brady KT; DeVane CL; Norton J
    Drug Alcohol Depend; 2015 Nov; 156():29-37. PubMed ID: 26386827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quitting Failure and Success With and Without Using Medication: Latent Classes of Abstinence and Adherence to Nicotine Monotherapy, Combination Therapy, and Varenicline.
    McCarthy DE; Versella MV
    Nicotine Tob Res; 2019 Oct; 21(11):1488-1495. PubMed ID: 30107419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study.
    Li F; Welling MC; Johnson JA; Coughlin C; Mulqueen J; Jakubovski E; Coury S; Landeros-Weisenberger A; Bloch MH
    J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):32-37. PubMed ID: 31800306
    [No Abstract]   [Full Text] [Related]  

  • 59. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls.
    Rabin RA; Kozak K; Zakzanis KK; Remington G; Stefan C; Budney AJ; George TP
    Schizophr Res; 2018 Apr; 194():47-54. PubMed ID: 28506704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies.
    Hart CL
    Drug Alcohol Depend; 2005 Nov; 80(2):147-59. PubMed ID: 15899556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.